Ryota Yoshimoto

2.2k total citations · 1 hit paper
50 papers, 1.8k citations indexed

About

Ryota Yoshimoto is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ryota Yoshimoto has authored 50 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Cardiology and Cardiovascular Medicine and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ryota Yoshimoto's work include Ion channel regulation and function (18 papers), Cardiac electrophysiology and arrhythmias (15 papers) and Receptor Mechanisms and Signaling (8 papers). Ryota Yoshimoto is often cited by papers focused on Ion channel regulation and function (18 papers), Cardiac electrophysiology and arrhythmias (15 papers) and Receptor Mechanisms and Signaling (8 papers). Ryota Yoshimoto collaborates with scholars based in Japan, United States and United Kingdom. Ryota Yoshimoto's co-authors include Junji Hamuro, Nobukazu Kashima, Tadatsugu Taniguchi, Hiroshi Matsui, Chikako Takaoka, Takashi Fujita, Akira Takahara, Shunsuke Kageyama, Hisayuki Uneyama and Hiroshi Yamamoto and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Hypertension.

In The Last Decade

Ryota Yoshimoto

49 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure and expression of a cloned cDNA for human interleukin-2

1983 961 citations Ryota Yoshimoto et al. profile →

Peers

Countries citing papers authored by Ryota Yoshimoto

Since Specialization

Citations

This map shows the geographic impact of Ryota Yoshimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryota Yoshimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryota Yoshimoto more than expected).

Fields of papers citing papers by Ryota Yoshimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryota Yoshimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryota Yoshimoto. The network helps show where Ryota Yoshimoto may publish in the future.

Co-authorship network of co-authors of Ryota Yoshimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ryota Yoshimoto. A scholar is included among the top collaborators of Ryota Yoshimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryota Yoshimoto. Ryota Yoshimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Calcified Honeycomb-shaped Collagen Maintains its Geometry in Vivo and Effectively Induces Vasculature and Osteogenesis 2009 ·Yoshinori Kuboki, (unknown), Ryota Yoshimoto, Tohru Kaku, Hiroko Takita, Dong Li, Yasuo Kokai, Shunji Yunoki, Rachel Sammons, (unknown), Teruo Miyata	7
2	Epithelioid Haemangioendothelioma of the Palate 2007 ·Asian Journal of Oral and Maxillofacial Surgery ·(unknown), Ryota Yoshimoto, Nobuyuki Tanaka, Tatsuru Ikeda	1
3	AT-1015, a novel serotonin2A receptor antagonist, improves resaturation of exercised ischemic muscle in hypercholesterolemic rabbits 2004 ·Journal of Vascular Surgery ·Takashi Komiyama, (unknown), Ken Hirose, Ryota Yoshimoto, Hiroshi Shigematsu	2
4	Effects of a dual L/N-type Ca2+ channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogs 2001 ·European Journal of Pharmacology ·(unknown), Akira Takahara, (unknown), (unknown), Ryota Yoshimoto	13
5	Utilization of Telemetry System to Assess the Cardiovascular Profile of AH-1058, a New Cardioselective Ca2+ Channel Blocker, in Conscious Dogs 2001 ·The Japanese Journal of Pharmacology ·Akira Takahara, (unknown), Ryota Yoshimoto, Atsushi Sugiyama, Keitaro Hashimoto	6
6	Antithrombotic activity of AT-1015, a potent 5-HT2A receptor antagonist, in rat arterial thrombosis model and its effect on bleeding time 2001 ·European Journal of Pharmacology ·(unknown), (unknown), Ken Hirose, Hiroshi Yamamoto, Ryota Yoshimoto	27
7	AH‐1058: A Novel Cardioselective Ca²⁺Channel Blocker 2001 ·Cardiovascular Drug Reviews ·Akira Takahara, Atsushi Sugiyama, Ryota Yoshimoto, Keitaro Hashimoto	4
8	Cardiovascular action of a cardioselective Ca2+channel blocker AH-1058 in conscious dogs assessed by telemetry 2001 ·European Journal of Pharmacology ·Akira Takahara, (unknown), Ryota Yoshimoto, Atsushi Sugiyama, Keitaro Hashimoto	10
9	Antiarrhythmic and cardiohemodynamic effects of a novel Ca2+ channel blocker, AH-1058, assessed in canine arrhythmia models 2000 ·European Journal of Pharmacology ·Akira Takahara, Atsushi Sugiyama, (unknown), Ryota Yoshimoto, Keitaro Hashimoto	10
10	AT-1015, a Novel Serotonin (5-HT)2 Receptor Antagonist, Blocks Vascular and Platelet 5-HT2A Receptors and Prevents the Laurate-Induced Peripheral Vascular Lesion in Rats 2000 ·Journal of Cardiovascular Pharmacology ·(unknown), Ken Hirose, (unknown), Noriko Sasaki, Hiroshi Yamamoto, (unknown), (unknown), (unknown), Ryota Yoshimoto	23
11	Electrophysiological and Cardiohemodynamic Effects of AH-1058, a New Type Calcium Channel Blocker, Assessed by the In Vivo Canine Model. 2000 ·The Japanese Journal of Pharmacology ·Akira Takahara, Atsushi Sugiyama, (unknown), Ryota Yoshimoto, Keitaro Hashimoto	7
12	Comparison of Cardiovascular Effects of a New Calcium Channel Blocker AH-1058 with Those of Verapamil Assessed in Blood-Perfused Canine Heart Preparations 2000 ·Journal of Cardiovascular Pharmacology ·Akira Takahara, Atsushi Sugiyama, (unknown), Ryota Yoshimoto, Keitaro Hashimoto	9
13	Inhibitory Effects of a Newly Synthesized 5-HT2 Receptor Antagonist, AT-1 015 (N-[2-[4-(5H-Dibenzo [a,d] cyclohepten-5-ylidene)piperidino]-ethyl]-1-formyl-4-piperidinecarboxamide Monohydrochloride Monohydrate), on Contraction and Relaxation of Pig Coronary Arteries Induced by 5-HT and .ALPHA.-Methylserotonin. Comparison with Ketanserin. 2000 ·Biological and Pharmaceutical Bulletin ·Hai‐Bin Gong, (unknown), Takashi Nakamura, (unknown), Mikio Nakazawa, (unknown), Ryota Yoshimoto, Takafumi Nagatomo	6
14	Effects of AH-1058, a New Antiarrhythmic Drug, on Experimental Arrhythmias and Cardiac Membrane Currents 1999 ·Journal of Cardiovascular Pharmacology ·Akira Takahara, Hisayuki Uneyama, Noriko Sasaki, Hiroko Ueda, (unknown), (unknown), Yukio Hara, Haruaki Nakaya, Ryota Yoshimoto	18
15	Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca2+ channels 1999 ·European Journal of Pharmacology ·Hisayuki Uneyama, Hirohisa Uchida, (unknown), Ryota Yoshimoto, Norio Akaike	38
16	Anti‐thrombotic effects and bleeding risk of AJvW‐2, a monoclonal antibody against human von Willebrand factor 1997 ·British Journal of Pharmacology ·Shunsuke Kageyama, Hiroshi Yamamoto, (unknown), Harumi Arisaka, Takashi Kayahara, Ryota Yoshimoto	76
17	Blockade of N‐type Ca²⁺ current by cilnidipine (FRC‐8653) in acutely dissociated rat sympathetic neurones 1997 ·British Journal of Pharmacology ·Hisayuki Uneyama, Akira Takahara, (unknown), Ryota Yoshimoto, (unknown), Norio Akaike	88
18	Antihypertensive effects of repeated oral administration of cilnidipine, a novel calcium antagonist, in 2K1C renal hypertensive dogs. 1995 ·Folia Pharmacologica Japonica ·Akira Takahara, Hirohisa Uchida, (unknown), (unknown), Ryota Yoshimoto, (unknown), (unknown), Ichiro Ono, Yoshinobu Takata, Hitoshi Kato	4
19	Effects of a New Dihydropyridine Derivative, FRC-8653, on Blood Pressure in Conscious Spontaneously Hypertensive Rats. 1992 ·Journal of Pharmacobio-Dynamics ·Ryota Yoshimoto, Yojiro Hashiguchi, (unknown), Masahiro Hosono, Hiroyuki Iida, (unknown), (unknown), Yutaka Hayashi	12
20	Prolonged Inhibition of Vascular Contraction and Calcium Influx by the Novel 1,4-Dihydropyridine Calcium Antagonist Cinaldipine (FRC-8653). 1991 ·The Japanese Journal of Pharmacology ·Ryota Yoshimoto, (unknown), Kaoru Yamada, Atsuo Goto	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact